103 related articles for article (PubMed ID: 31829825)
1. Oxidative stress in CLL patients leads to activation of Th9 cells: an experimental and comprehensive survey.
Sabry SA; El-Senduny FF; Abousamra NK; Salah El-Din M; Youssef MM
Immunol Med; 2020 Mar; 43(1):36-46. PubMed ID: 31829825
[TBL] [Abstract][Full Text] [Related]
2. [Expression and Clinical Significance of Helper T Cells 9 and Its Sytokines Interleukin 9 in Chronic Lymphocytic Leukemia].
Shabaaiti T; Pang NN; Xierenguli A; Nazhakaiti Y; Guo S; Zhang RR; Gong S; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1663-1669. PubMed ID: 38071043
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
4. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
Schuler M; Tretter T; Schneller F; Huber C; Peschel C
Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Ringelstein-Harlev S; Avivi I; Fanadka M; Horowitz NA; Katz T
Cancer Immunol Immunother; 2018 May; 67(5):739-748. PubMed ID: 29450641
[TBL] [Abstract][Full Text] [Related]
7. GIFT4 fusokine converts leukemic B cells into immune helper cells.
Deng J; Pennati A; Cohen JB; Wu Y; Ng S; Wu JH; Flowers CR; Galipeau J
J Transl Med; 2016 Apr; 14(1):106. PubMed ID: 27118475
[TBL] [Abstract][Full Text] [Related]
8. Increased IL-10/IL-17 ratio is aggravated along with the prognosis of patients with chronic lymphocytic leukemia.
Pang N; Zhang R; Li J; Zhang Z; Yuan H; Chen G; Zhao F; Wang L; Cao H; Qu J; Ding J
Int Immunopharmacol; 2016 Nov; 40():57-64. PubMed ID: 27584054
[TBL] [Abstract][Full Text] [Related]
9. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
11. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
Hammond C; Shi Y; Mena J; Tomic J; Cervi D; He L; Millar AE; Debenedette M; Schuh AC; Baryza JL; Wender PA; Radvanyi L; Spaner DE
J Immunother; 2005; 28(1):28-39. PubMed ID: 15614042
[TBL] [Abstract][Full Text] [Related]
12. A deleterious role for Th9/IL-9 in hepatic fibrogenesis.
Qin SY; Lu DH; Guo XY; Luo W; Hu BL; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX; Zhou Y
Sci Rep; 2016 Jan; 6():18694. PubMed ID: 26728971
[TBL] [Abstract][Full Text] [Related]
13. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
[TBL] [Abstract][Full Text] [Related]
14. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
[TBL] [Abstract][Full Text] [Related]
15. T-cell chronic lymphocytic leukemia with a helper/inducer membrane phenotype: a distinct clinicopathologic subtype with a poor prognosis.
Witzig TE; Phyliky RL; Li CY; Homburger HA; Dewald GW; Handwerger BS
Am J Hematol; 1986 Feb; 21(2):139-55. PubMed ID: 2934974
[TBL] [Abstract][Full Text] [Related]
16. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL).
Rossmann ED; Lewin N; Jeddi-Tehrani M; Osterborg A; Mellstedt H
Eur J Haematol; 2002 May; 68(5):299-306. PubMed ID: 12144536
[TBL] [Abstract][Full Text] [Related]
17. [T lymphocyte subpopulations in B-cell chronic lymphocytic leukemia patients with a different percentage of CD4+ helper T cells in bone marrow].
Roliński J; Rupniewska ZM; Wasik-Szczepanek E
Pol Arch Med Wewn; 1998 Dec; 100(6):526-35. PubMed ID: 10405565
[TBL] [Abstract][Full Text] [Related]
18. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
Lu G; Kong Y; Yue C
Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
[TBL] [Abstract][Full Text] [Related]
20. New perspectives on the approach to chronic lymphocytic leukemia.
Goodman MG; Spinosa JC; Saven A; Piro LD; Wormsley S
Leuk Lymphoma; 1996 Jun; 22(1-2):1-10. PubMed ID: 8724523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
